TGA Approval

ATROVENT NASAL FORTE ipratropium bromide monohydrate 44 microgram/actuation spray solution (67490)

ARTG ID

67490

ARTG Name

ATROVENT NASAL FORTE ipratropium bromide monohydrate 44 microgram/actuation spray solution

Sponsor

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

ARTG Date

May 25, 1999

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

SANOFI-AVENTIS HEALTHCARE PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01305-1

Ingredient Name

ipratropium bromide

Empowering clinical research with data-driven insights and AI-powered tools.